GUARDIAN-101: A Phase 1 Dose Escalation and Expansion Study of CLSP-1025 in Adult Patients with Solid Tumors that Harbor the p53 R175H Mutation

Disease Name: 
Solid tumors
Study Status: 
Date: 
August 7, 2025